Artivion | CRY - 贷款资金



金融业
股票价格
USD
资产
USD 1.07B
现金及等价物
USD 77.32M
销售成本
USD 42.85M
流动资产
USD 371.38M
流动负债
USD 106.93M
债务
USD 317.78M
EBIT
USD 4.79M
EBITDA
USD 22.72M
员工
1.5K
EPS每股收益
USD -0.02
股本和储备
USD 445.59M
销售毛利
USD 73.14M
债务利息支出
USD 5.53M
利息收入
USD -0.05
贷款资金
USD 363.42M
市值
USD 1.01B
净收入
USD 2.42M
营业费用
USD 111.2M
营业利润
USD 4.79M
普通股股本
USD 47.84M
PE价格收益
212.38
税前利润
USD 11.4M
销售收入
USD 115.99M
销售和管理费用
USD 55.75M
股票
USD 103.36M
贸易债权人
USD 20.87M
应收帐款人
USD 103.68M


贷款资金 更改 日
Abbott USD 29.64B 19.74B 2026-03
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 5.6M 100K 2025-09
Artivion USD 363.42M 148.07M 2026-06
AtriCure USD 61M 0 2026-06
Baxter International USD 8.62B 6M 2026-06
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Boston Scientific USD 10.86B 148M 2026-03
Edwards Lifesciences USD 598.7M 1.3M 2026-06
Inogen USD 0 0 2022-06
Integra LifeSciences USD 1.83B 2.05M 2026-06
J&J USD 37.34B 183M 2026-06
Mesa Laboratories USD 104.2M 104.3M 2024-09
Orthofix International USD 221.59M 256K 2026-06
Pfizer USD 60.5B 70M 2026-06
ResMed USD 399.42M 4.75M 2026-06
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 809K 2026-06
Teleflex USD 2.72B 206.24M 2026-06
Terumo JPY 209.52B 109.61B 2026-06
Trinity Biotech USD 16.33M 98.53M 2025-12